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Abstract
OBJECTIVE: To evaluate inhibition effect and mech-
anism of compound ethanol extracts from Wuweizi
(Fructus Schisandrae Chinensis), Chuanxiong (Rhi-
zoma Chuanxiong) and Muli (Cocha Ostreae) (FRC)
on glomerular and tubular interstitial fibrosis in
streptozocin (STZ)-induced diabetic nephropathy
(ND) model mice.
METHODS: Twenty-seven male C57BL/6 mice were
divided randomly into 3 groups: nondibetic (ND),
STZ-induced diabetic (D), and STZ-induced diabetic
that were treated with 5 g·kg-1·day-1of FRC by oral
gavage (DFRC), with 9 in each group. The protein ex-
pressions of E-cadherin, α-smooth muscle actin
(α-SMA), Plasminogen Activator Inhibitor-1 (PAI-1)
in renal tissues were investigated by Western blot-
ting. The expressions of fibronectin (FN) and α-SMA
were detected by immunohistochemical method.
The morphological changes of renal tissues were
observed under a microscope.
RESULTS: Renal tissues in the DFRC group showed a
lessened degree of fibrosis. Meanwhile, the expres-
sions of FN, α-SMA and PAI-1were significantly
lower in the DFRC group than those in the D group
(all P<0.05).
CONCLUSION: FRC can ameliorate the DN in the
C57BL/6 mice, and its mechanism may relate to in-
hibition on the epithelial to mesenchymal transdif-
ferentiation, endothelial-myofibroblast transition
and PAI-1 expression.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Diabetic nephropathy (DN), one of the major micro-
vascular complications of diabetes mellitus, is the larg-
est single cause of end-stage renal failure worldwide.1
Glomerular and tubular basement membranes, in-
creased deposition of extracellular matrix (ECM) and
interstitial fibrosis are the key morphological features
of DN. The pathogenesis of the DN is complex and
conventional treatments including strict diet, blood
pressure control by taking antihypertensive drugs, and
blood sugar control by antidiabetic drugs and insulin,
play an effective role in reducing leakage of urine pro-
tein and protecting renal function. However, as of now,
no specific treatments can be taken for inhibiting and
reversing the fibrosis in the clinic.2
Wuweizi (Fructus Schisandrae Chinensis), sour in fla-
vor, warm in nature, and attributive to the lung, heart
and kidney meridians, can astringe the lung to treat
cough and asthma and nourish the kidney, promote
the production of body fluid and constrain perspira-
tion, astringe the essence and stop diarrhea, and nour-
ish the heart and calm the mind. Modern pharmacolog-
ical studies indicate that it has the effects of anti-in-
flammation, anti-oxidation, scavenging oxygen free rad-
icals, increasing glucose uptake, and preventing and
protecting renal ischemia-reperfusion injury. Chuanx-
iong (Rhizoma Chuanxiong), a kind of blood-activat-
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ing and stasis-removing drugs used in Traditional Chi-
nese Medicine, can promote the circulation of the
blood and Qi, inhibit platelet aggregation and abnor-
mal proliferation, and produce anti-fibrosis, anti-oxida-
tion and anti-apoptosis effects as well. Muli (Cocha Os-
treae), which has properties that calm the liver, sup-
press the hyperactive Yang, soften hardness and dis-
perse the stagnated mass, invigorate the kidney to pre-
serve essence, and reduce glomerular capillary vessel
permeability and protein leakage, has been clinically
used to treat hyperactive Yang due to Yin deficiency
syndrome. The major components of these drugs were
all fat-soluble.
In the present study, we evaluated the efficiency and
mechanism of the compound ethanol extracts from
Wuweizi (Fructus Schisandrae Chinensis), Chuanxiong
(Rhizoma Chuanxiong) and Muli (Cocha Ostreae)
(FRC) in treating streptozocin (STZ)-induced DN
model mice.
MATERIAL ANDMETHODS
Animal model preparation
Studies were performed on male C57Bl/6 mice (6-
7 weeks, 20-25 g), which obtained from Laboratory
Animal Center, the College of Life Sciences, Nankai
University. After feeding high-fat diet for 4 weeks, the
mice were given a single intraperitoneal injection of
25 mg/kg STZ. The diabetic mice were selected when
the blood glucose reading of above 7.0 mmol/L and
11.0 mmol/L at 0 and 120 min respectively, using the
oral glucose tolerance test by 2 weeks after STZ. Diabe-
tes model was generated in the diabetic mice after a fat
diet for 4 weeks.
Experimental groups and methods
The male C57Bl/6 mice were housed in a temperature-
and humidity-controlled environment (22° C-24° C,
50%-70% ) on a normal 12 h light-dark cycle from
7AM to 7PM and maintained on regular chow and wa-
ter ad libitum. The mice were divided randomly into 3
groups: nondibetic (ND), STZ-induced diabetic (D),
and STZ-induced diabetic that were treated with 5 g·
kg-1·day-1of FRC by oral gavage (DFRC), with 9 in each
group. Nondiabetic and untreated diabetic animals
were orally gavaged daily with equivalent volumes of
distilled water. The oral gavage was taken once per day
at 4PM for 9 weeks. All experiments were approved by
the Institutional Animal Care and Use Committee.
Reagents and antibodies
FRC contains Fructus Schisandrae Chinensis, Rhizoma
Chuanxiong and Cocha Ostreae at the ratio of 3∶2∶1.
The mixture was extracted twice by refluxing it with
90% ethanol for 3 h, and then the extract was precipi-
tated, filtered, evaporated into extractum, and pre-
served at -20°C.
STZ, bovine serum albumin (BSA, chromatographical-
ly pure), padioimmunoprecipitation buffer, periodic ac-
id silver methanamine, sodium dodecyl sulfate (SDS),
and creatinine (chromatographically pure) were ob-
tained from Sigma (St Louis, MO, USA); phenobarbi-
tal sodium was from Beijing Da Tian Feng Tuo Chem-
istry Technology Co. Ltd, Na2HPO4 (chromatographi-
cally and analytically pure); KH2PO4 and citric acid
(analytically pure), NaCl, and HCl were all from Tian-
jin Bei Fang Tian Yi Chemical Regent Factory; Trizma
HCl and Tween20 were from Tianjin Fine Chemical in-
stitute, absolute methanol and 40% formaldehyde solu-
tion were from Tianjin Chemical Reagent Co. Ltd;
Glycerin ethanol Clear-Mount was from Beijing
Zhong Shan Golden Bridge biotechnology Co. Ltd;
protease inhibitor, calcineurin inhibitor, bicinchoninic
acid protein assay kit were from Thermo Fisher Scien-
tific (Waltham, Massachusetts, USA); 3-amino-9-ethyl-
carbozole Chromogenic (AEC) kit were from Vector
laboratories (Burlingame, CA, USA); Tris, glycine,
acrylamide, methylene bisacrylamide Ammonium per-
sulfate and etramethyl ethylene diamine were from Bio
basic inc (Ontario, Canada).
Antibodies used in this study were: mouse anti-mouse
fibronectin (FN) (sc-71113,Santa Cruz Biotechnolo-
gies Inc, Santa Cruz, CA, USA); mouse anti-mouse
E-cadherin (5296S,cell signal Technology,Beverly, MA,
USA); mouse anti-mouse α-SMA ( A2547,Sigam, St.
Louis, MO, USA); mouse anti-mouse β-actin
(sc-81178, Santa Cruz Biotechnologies Inc, Santa
Cruz, CA, USA); and goat anti–mouse immunoglob-
ulin G (IgG)-horseradish peroxidase(sc-2005, Santa
Cruz Biotechnologies Inc, Santa Cruz, CA, USA).
Sample collection
The mice were anesthetized with intraperitoneal injec-
tions of pentobarbital (250 μg /kg), then the kidneys
were dissected and the cortexes were scraped off. One
third of one kidney was fixed in a para-formaldehyde
solution for further paraffin imbedding; one third was
inflated with optimum cutting temperature (OCT) me-
dium, embedded in OCT, and stored in a refrigerator
at -70°C for slice frosting; and the rest third and the
other kidney was snap-frozen in liquid nitrogen at -70°
C for Western blotting.
Quantitative evaluation of fibrosis
After fixation, kidneys were embedded in paraffin, sec-
tioned at 2 μm and 3 μm, stained on separate glass
slides with Gomori Periodic Acid Silver Methanamine
and Masson's trichrome, and observe the histological
structure of kidney under a light microscope.
Immunohistochemistry analysis
Dewaxed formalin-fixed kidney paraffin sections
(3 μm) were incubated with 0.6% hydrogen perox-
ide for 20 min each to block nonspecific immunola-
beling. The sections were under microwave antigen re-
trieval for 20 min and blocked in 2% bovine serum al-
bumin (BSA) for 1 h. The sections were incubated with
primary antibody (FN polyclonal antibody) at 4°C over-
night. After being washed with Tris Buffered Saline
with Tween (TBST) for three times (10 min per time)
the next day, sections were incubated with secondary
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biotinylated antibody goal anti-mouse (dilution 1∶
100 in 2% BSA), and subsequently subjected to incu-
bation with the Avidin-Biotin Peroxidase Complex for
1 h at room temperature. After being colorated with
AEC, sections were slightly smeared with hematoxy-
lin, rinsed with tap water or PBS, dehydrated and
mounted. The expression of FN was observed under a
microscope.
Double Immunofluorescence
The frozen sections were transferred at -20°C for 15 min,
then at room temperature for 15 min. Sections were
fixed in formaldehyde for 10 min, then blocked in 2%
bovine serum albumin (BSA) at room temperature for
1 h, and incubated with primary antibodies including
mouse anti-α-SMA and mouse anti-CD31 at 4°C over-
night, followed with incubation with fluorescein iso-
thiocyanate-labeled secondary antibodies (α- SMA
(green), CD31 (red); dilution, 1:100). 4, 6-diamidi-
no-2-phenylindole (DAPI) was used as a nuclear stain.
The expressions of α-SMA and CD31 were observed
under a fluorescence microscopy.
Western blotting
The kidney tissues stored at -70°C were selected from all
the groups, chopped into small pieces, gently homoge-
nized, washed by centrifugation (12000 rpm×15min) at
4°C, and determined protein concentrations. Aliquots
of protein were treated with double-distilled water and
SDS, then heated at 100°C for 8 min and fractionated
in a 10% SDS-polyacrylamide gel. The proteins were
then transferred to nitrocellulose membrane and
blocked with 5% skim milk for 1 h. After blocking, blots
were incubated with α-SMA (dilution, 1∶2000) over-
night at 4°C, and then added secondary antibodies conju-
gated to horseradish peroxidas for 1 h. The membranes
were washed thoroughly with TBST and visualized by
electrochemiluminescence detection system.
Statistical analysis
Statistical analysis was performed using the SPSS 17.0
statistical analysis program. One-way analysis of vari-
ance was used to determine statistical differences be-
tween multiple groups. Data were recorded as the
means±SD unless specified and values of P<0.05 were
considered significant.
RESULTS
Histological evaluation
PASM staining of renal tissues showed thickening of
the glomerular basement membrane, tubular dilation
and cast formation in glomeruli in the D group at
week 9 compared with the ND group. The severity of
hepatic fibrosis in the DFRC mice was significantly less-
ened compared with the ND group. Glomeruli and tu-
bule in the ND mice were normal in structure and
morphology (Figure 1). Masson's trichrome staining of
renal tissues showed that blue fibrosis deposition was
found in the D group, but not in the ND and DFRC
groups (Figure 2).
FN expression by Immunohistochemistry analysis
Immunohistochemistry showed that in the ND mice,
FN presented a liner expression in the tubular base-
ment membrane and glomeruli, and no positive expres-
sion in the renal interstitium. In the D mice, FN ex-
pression increased obviously in glomeruli and tubuloin-
terstitium, especially in the renal interstitium around
the tubules and glomerular mesangium. After the FRC
treatment, FN expression in the DFRC mice was greatly
decreased (Figure 3).
CD31 and α-SMA Expressions by double
immunofluorescence
In the ND group, CD31 expression was observed in
the glomeruli and great vessels, while α-SMA expres-
sion only in the great vessels. Both CD31 and α-SMA
expressions were observed in the great vessels but not
other regions in the composite graph. In the D group,
a large amount of α-SMA was observed in the glomeru-
li at week 9, and the glomeruli and great vessels co-ex-
pressed CD31 and α-SMA in the composite graph. In
the DFRC group, a small amount of α-SMA was ob-
served in the glomeruli, and in the composite graph no
co-expressions could be found (Figure 4).
PAI-1, E-cadherin and α-SMA protein expressions
by western blotting
Western blotting showed that expressions of PAI-1 andα-SMA in the D group were higher than these in the
ND and DFRC groups (all P<0.05), whereas E-cadherin
expression was lower (all P<0.05). Treatment with FRC
resulted in a decreased expression of α-SMA compared
with the D group (P=0.019) and it showed no signifi-
cantly difference with the ND group (P=0.041) (Table
1, Figure 5).
DISCUSSION
Currently, little is known about the mechanism of the
DN, and in modern medicine, the symptomatic treat-
ments such as blood glucose and blood pressure con-
trol could not ameliorate the kidney function.3 The de-
position of the ECM can induce the fibrosis of glomer-
uli and tubulointerstitium, which is another DN sym-
bolic feature besides urinary albumin. Myofibroblast
(MF) secretes the precursor components of the ECM,
and FN is one of major proteins of ECM. Primary
pathological manifestations of renal interstitial fibrosis
are deposition of ECM, tubular atrophy and increment
of interstitial MF levels.4,5 Interstitial MF mainly devel-
oped from bone marrow stem cells, transformed from
renal tubular epithelial cells and activated from partial
fibroblasts of renal interstitium. Studies have found
that the MF from epithelial to mesenchymal transdif-
ferentiation (EMT) makes up about 36% of overall
newly increased MF in renal interstitium, 6, 7 which in-
dicate that EMT may be an important mechanism of
renal interstitial fibrosis.
671
JTCM |www. journaltcm. com December 15, 2012 |volume 32 | Issue 4 |
Zhang YQ et al. Compound ethanol extracts fromWuweizi on RIF in diabetic nephropathy
The present study showed that the marker protein of
epithelial cells E-cadherin level in the D group is lower
than that in the DN group, and unregulated after 9
weeks of treatments. The marker protein of MFα-SMA level in the D mice was higher than the DN
and DFRC mice. Compared with the D group, the ex-
pressions of α-SMA and FN in the DFRC group were ob-
viously decreased, and less fibrosis deposition was ob-
served according to Masson staining. These suggested
that FRC can inhibit the transformation of the epitheli-
al cells to MF, reduce the ECM, and thereby prevent re-
nal interstitial fibrosis.
PAI-1 can inhibit the plasminogen activation, decrease
the ECM degradation, and promote the ECM tissue
accumulation. Previous studies have showed that the
PAI-1gene exprssion was elevated in the renal fibrosis
A B C
Figure 2 Photomicrographs of Masson's trichrome-stained sections among different groups. (Original magnification ×400)
A: ND group, B: D group, C: DFRC group; ND: nondibetic, D: STZ-induced diabetic, DFRC: STZ-induced diabetic treated with FRC,
FRC: compound ethanol extracts fromWuweizi (Fructus Schisandrae Chinensis), Chuanxiong (Rhizoma Chuanxiong) and Muli (Co-
cha Ostreae).
Figure 1 Photomicrographs of Gomori Periodic Acid Silver Methanamine-stained sections among different groups. (Original mag-
nification ×1000)
A: ND group, B: D group, C: DFRC group; ND: nondibetic, D: STZ-induced diabetic, DFRC: STZ-induced diabetic treated with FRC,
FRC: compound ethanol extracts fromWuweizi (Fructus Schisandrae Chinensis), Chuanxiong (Rhizoma Chuanxiong) and Muli (Co-
cha Ostreae).
A B C
Figure 3 Immunohistochemistry for FN expression changes
A: ND group, B: D group, C: DFRC group; ND: nondibetic, D: STZ-induced diabetic, DFRC: STZ-induced diabetic treated with FRC,
FRC: compound ethanol extracts fromWuweizi (Fructus Schisandrae Chinensis), Chuanxiong (Rhizoma Chuanxiong) and Muli (Co-
cha Ostreae).
A B C
Figure 4 α-SMA and CD31double labeling
A: ND group, B: D group, C: DFRC group; ND: nondibetic, D:
STZ-induced diabetic, DFRC: STZ-induced diabetic treated
with FRC, FRC: compound ethanol extracts from Wuweizi
(Fructus Schisandrae Chinensis), Chuanxiong (Rhizoma Ch-
uanxiong) and Muli (Cocha Ostreae); Kidney sections were
double stained with antibodies to α-SMA (green) and CD31
(red); Yellow color in the merged panel indicates coexpres-
sion of α-SMA and CD31.
CD31 SMA CD31/α-SMA
C
B
A
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region, which decreased the progression of the fibro-
sis.8-10 The result of the present study found that PAI-1
expression in the DFRC group was lower than the D
group, and showed no significantly difference as com-
pared with the ND group, which indicated FRC could
inhibit the PAI-1 expression, increase the ECM degra-
dation, and sequentially improve the DN.
In summary, in this study, we used the DN mice mod-
el based on the study by professor Zhang,11 and found
that after the mice oral gavaged the FRC, the severity
of renal fibrosis was lessened markedly, the levels of
E-cadherin and CD31 upregulated, and the expres-
sions of PAI-1, α-SMA and FN downregulated. These
strongly indicated that FRC could ameliorate the pro-
gression of DN in C57BL/6 mice, and its mechanism
may relate to reducing the ECM generation through in-
hibiting the proliferation of glomeruli mesangial cells,
activating the MF and differentiating the EndMT, pro-
moting the ECM degradation, and inhibiting the
EMT and the PAI-1 expression.
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Table 1 PAI-1, E-cadherin and α-SMA protein expressions among different groups ( xˉ ±s)
Group
ND
D
DFRC
F
P (ND vs D)
P (ND vs DFRC)
P (D vs DFRC)
n
9
9
9
-
-
-
-
PAI-1/β-actin
0.0142±0.0031
0.2712±0.0780
0.0188±0.0024
19.672a
0.012
0.928
0.013
E-cadherin/β-actin
0.7825±0.0883
0.2241±0.0831
0.5565±0.0100
32.002b
0.004
0.049
0.018
α-SMA/β-actin
0.0471±0.0616
1.2221±0.1418
0.5515±0.2003
32.560b
0.004
0.041
0.019
Notes: ND: nondibetic, D: STZ-induced diabetic, DFRC: STZ-induced diabetic treated with FRC, FRC: compound ethanol extracts
from Wuweizi (Fructus Schisandrae Chinensis), Chuanxiong (Rhizoma Chuanxiong) and Muli (Cocha Ostreae), α-SMA: α-smooth
muscle actin, PAI-1: Plasminogen Activator Inhibitor-1; Significant difference among the groups in the same row by one-way ANOVA at
aP<0.05, bP<0.01.
Figure 5 Representative protein expression of
α-SMA among different groups
A: ND group, B: D group, C: DFRC group; ND: non-
dibetic, D: STZ-induced diabetic, DFRC: STZ-in-
duced diabetic treated with FRC, FRC: compound
ethanol extracts from Wuweizi (Fructus Schisan-
drae Chinensis), Chuanxiong (Rhizoma Chuanx-
iong) and Muli (Cocha Ostreae), α-SMA: α-smooth
muscle actin; β-actin was used as an equal load-
ing control.
43Ka
43Ka
A B C
α-SMA
β-actin
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